NDC 68982-810
Cutaquig
Immunoglobulin G
Cutaquig is a Subcutaneous Solution in the Plasma Derivative category. It is labeled and distributed by Octapharma Usa Inc. The primary component is Human Immunoglobulin G.
| Product ID | 68982-810_1034d029-04d1-1503-9c99-050051595669 |
| NDC | 68982-810 |
| Product Type | Plasma Derivative |
| Proprietary Name | Cutaquig |
| Generic Name | Immunoglobulin G |
| Dosage Form | Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2019-05-03 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125668 |
| Labeler Name | Octapharma USA Inc |
| Substance Name | HUMAN IMMUNOGLOBULIN G |
| Active Ingredient Strength | 165 mg/mL |
| Pharm Classes | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
Packaging
NDC 68982-810-01
1 VIAL, GLASS in 1 CARTON (68982-810-01) > 6 mL in 1 VIAL, GLASS (68982-810-81)
| Marketing Start Date | 2019-05-03 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 68982-810-81 [68982081081]
Cutaquig SOLUTION
| Marketing Category | BLA |
| Application Number | BLA125668 |
| Product Type | LOT DISTRIBUTION DATA |
| Billing Unit | ML |
| Marketing Start Date | 2019-05-03 |
NDC 68982-810-83 [68982081083]
Cutaquig SOLUTION
| Marketing Category | BLA |
| Application Number | BLA125668 |
| Product Type | LOT DISTRIBUTION DATA |
| Billing Unit | ML |
| Marketing Start Date | 2019-05-03 |
NDC 68982-810-03 [68982081003]
Cutaquig SOLUTION
| Marketing Category | BLA |
| Application Number | BLA125668 |
| Product Type | LOT DISTRIBUTION DATA |
| Billing Unit | ML |
| Marketing Start Date | 2019-05-03 |
NDC 68982-810-01 [68982081001]
Cutaquig SOLUTION
| Marketing Category | BLA |
| Application Number | BLA125668 |
| Product Type | LOT DISTRIBUTION DATA |
| Billing Unit | ML |
| Marketing Start Date | 2019-05-03 |
NDC 68982-810-02 [68982081002]
Cutaquig SOLUTION
| Marketing Category | BLA |
| Application Number | BLA125668 |
| Product Type | LOT DISTRIBUTION DATA |
| Billing Unit | ML |
| Marketing Start Date | 2019-05-03 |
NDC 68982-810-86 [68982081086]
Cutaquig SOLUTION
| Marketing Category | BLA |
| Application Number | BLA125668 |
| Product Type | LOT DISTRIBUTION DATA |
| Billing Unit | ML |
| Marketing Start Date | 2019-05-03 |
NDC 68982-810-05 [68982081005]
Cutaquig SOLUTION
| Marketing Category | BLA |
| Application Number | BLA125668 |
| Product Type | LOT DISTRIBUTION DATA |
| Billing Unit | ML |
| Marketing Start Date | 2019-05-03 |
NDC 68982-810-04 [68982081004]
Cutaquig SOLUTION
| Marketing Category | BLA |
| Application Number | BLA125668 |
| Product Type | LOT DISTRIBUTION DATA |
| Billing Unit | ML |
| Marketing Start Date | 2019-05-03 |
NDC 68982-810-85 [68982081085]
Cutaquig SOLUTION
| Marketing Category | BLA |
| Application Number | BLA125668 |
| Product Type | LOT DISTRIBUTION DATA |
| Billing Unit | ML |
| Marketing Start Date | 2019-05-03 |
NDC 68982-810-82 [68982081082]
Cutaquig SOLUTION
| Marketing Category | BLA |
| Application Number | BLA125668 |
| Product Type | LOT DISTRIBUTION DATA |
| Billing Unit | ML |
| Marketing Start Date | 2019-05-03 |
NDC 68982-810-84 [68982081084]
Cutaquig SOLUTION
| Marketing Category | BLA |
| Application Number | BLA125668 |
| Product Type | LOT DISTRIBUTION DATA |
| Billing Unit | ML |
| Marketing Start Date | 2019-05-03 |
NDC 68982-810-06 [68982081006]
Cutaquig SOLUTION
| Marketing Category | BLA |
| Application Number | BLA125668 |
| Product Type | LOT DISTRIBUTION DATA |
| Billing Unit | ML |
| Marketing Start Date | 2019-05-03 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| HUMAN IMMUNOGLOBULIN G | 165 mg/mL |
Pharmacological Class
- Human Immunoglobulin G [EPC]
- Passively Acquired Immunity [PE]
- Antigen Neutralization [MoA]
- Immunoglobulins [CS]
NDC Crossover Matching brand name "Cutaquig" or generic name "Immunoglobulin G"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0069-1061 | Cutaquig | immunoglobulin G |
| 0069-1476 | Cutaquig | immunoglobulin G |
| 0069-1509 | Cutaquig | immunoglobulin G |
| 0069-1802 | Cutaquig | immunoglobulin G |
| 0069-1960 | Cutaquig | immunoglobulin G |
| 0069-1965 | Cutaquig | immunoglobulin G |
| 68982-810 | Cutaquig | immunoglobulin G |
Trademark Results [Cutaquig]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 CUTAQUIG 87225330 5880441 Live/Registered |
Octapharma AG 2016-11-03 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.